The latest selling price and patient purchasing guide of upadatinib

Upadatinib, as an innovative oral drug, has been widely used in the treatment of adults with moderate to severe active rheumatoid arthritis (RA), active psoriatic arthritis (PsA), active ankylosing spondylitis (AS) and other autoimmune diseases, as well as refractory moderate to severe atopic dermatitis (AD). It effectively relieves joint inflammation caused by excessive activation of JAKs, such as pain, swelling and stiffness, by precisely blocking the key enzyme Janus kinases (JAKs). Upadatinib has become a new option for patients when methotrexate and tumor necrosis factor inhibitors are ineffective or unsuitable.

Currently, the original drug of upadatinib is on the market in my country, but its price is high due to high research and development costs and complex production processes. This puts a huge financial strain on patients who require long-term treatment. Fortunately, domestic patients can obtain partial reimbursement through medical insurance policies, which greatly reduces the pressure of purchasing medicines. In addition, there are cheap generic versions overseas. Taking the Laos version of upadatinib as an example, each box of 15mg*30 tablets is priced at about five to six hundred yuan, which is significantly lower than the price of the original drug. The price of the Bangladeshi version with the same specifications is slightly higher, about between 700 and 800 yuan.

When purchasing upadatinib, patients need to pay special attention to the source and channels of the drug. It is recommended to choose regular pharmacies or overseas medical institutions to purchase, and carefully check key information such as the packaging, manufacturer, and expiration date of the medicine to ensure that you are purchasing genuine medicines. At the same time, patients need to reasonably choose drug specifications and dosage based on their own condition and doctor’s advice.

In short, upadatinib is a highly effective drug for treating autoimmune diseases. Although it is expensive, patients can still effectively reduce their financial burden through medical insurance reimbursement and the purchase of generic drugs. When purchasing, be sure to choose the channel carefully to ensure the quality of the medicine.

References:

https://rheumatology.org/patients/upadacitinib-rinvoq